Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bill & Melinda Gates Foundation
Headquarters: Seattle, WA, United States of America
Website: http://www.gatesfoundation.org...
Year Founded: 1997
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Mar 29, 2025
Management Tracks
Aurion names Arnaud Lacoste CEO
Plus: David de Vries named CEO of Tr1x, and updates from Crispr, Pacbio, Alvotech and Tscan
BioCentury | Mar 27, 2025
Regulation
FDA hit by massive cuts that could lead it to miss PDUFA goals
Cuts devised by acting commissioner with no input from center directors
BioCentury | Mar 20, 2025
Data Byte
FDA’s new and supplemental approvals in February
Springworks gets priority review voucher for Gomekli, first NovoLog biosimilar reaches market, and more
BioCentury | Mar 18, 2025
Data Byte
Wuxi stocks bounce back as Biosecure threat fades
Shares of Wuxi Apptec and Wuxi Biologics are closing in on pre-Biosecure levels
BioCentury | Mar 15, 2025
Politics, Policy & Law
It’s been a year: BIO CEO Crowley’s plans for Trump 2.0
BIO is engaging Trump to protect and improve FDA, hoping to dodge tariffs, looking for paths to modify IRA and reinstate PRVs
BioCentury | Mar 14, 2025
Management Tracks
Rui Santos Ivo elected as new chair at EMA
Plus: Jane Chung named CEO of Sutro after strategic review, and Richard Law becomes CBO at Haya
BioCentury | Mar 13, 2025
Politics, Policy & Law
Abortion, vaccine politics overshadow votes on heads of FDA, NIH
Senate committee endorsement of Makary at FDA and Bhattacharya at NIH came after resignation of FDA chief counsel, withdrawal of CDC director nominee
BioCentury | Mar 12, 2025
Politics, Policy & Law
House spending bill omits PRV reauthorization, slashes biomedical research program
Fate of continuing resolution in doubt as Senate Democrats balk ahead of Friday deadline to avert government shutdown
BioCentury | Mar 1, 2025
Editor's Commentary
HHS, DOGE make a mockery of transparency, COI pledges — a Perspective
HHS Secretary Kennedy says he won’t consult public on rules, DOGE staff have obvious financial conflicts
BioCentury | Feb 25, 2025
Politics, Policy & Law
Tough path for pill penalty fix
Bipartisan House bill to extend IRA price negotiation window for small molecules to 13 years faces steep future
Items per page:
1 - 10 of 3180